Back to results
US 2021/0198256 A1Published application
Compounds for the degradation of brd9 or mth1
AssigneeC4 Therapeutics, Inc.
InventorsChristopher G. Nasveschuk, Ning Yin, Katrina L. Jackson, Gesine Kerstin Veits, Moses Moustakim, Jeremy L. Yap, Rhamy Zeid
Life of this patent
Estimating the term…
Abstract
Compounds that degrade BRD9 or MTH1 via the ubiquitin proteasome pathway in a subject in need thereof for therapeutic applications are provided. The compounds provided have an E3 Ubiquitin Ligase targeting moiety (Degron) that is linked to a Targeting Ligand for BRD9 or MTH1.
Claims20
A compound selected from:
- or a pharmaceutically acceptable salt thereof;
- wherein:
- Degron is selected from:
- D1 is selected from:
- TL1 is a moiety that binds to BRD9 selected from
- TL2 is a moiety that binds to BRD9 selected from
- L1 is selected from:
- X1, X2, X3, and X4 are independently selected from CR4 and N, wherein no more than two of X1, X2, X3, and X4 may be selected to be N;
- X5 and X6 are independently selected from CR4 and N;
- Z2 and Z3 are selected from —CH2— and —C(O)— wherein at least one of Z2 and Z3 is —C(O)—;
- n is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10;
- o is 1, 2, 3, or 4;
- each Q is independently 0, S, or NR5;
- R1 is hydrogen or C1-C6 alkyl;
- R2, R3, and R6 are independently selected from hydrogen and C1-C6alkyl;
- each R4 is independently selected from hydrogen, halogen, hydroxyl, C1-C6alkyl, C1-C6alkoxy, and C1-C6haloalkyl;
- each R5 is independently hydrogen, C1-C6alkyl, or —C(O)alkyl;
- R7 is selected from halogen, hydrogen, C1-C6alkyl, C1-C6alkoxy, and C1-C6haloalkyl;
- each R8 is independently selected from hydrogen, C1-C6alkyl, and C1-C6haloalkyl;
- or two R8 groups together with the carbon to which they are attached form a cyclopropyl group;
- L2 is selected from:
- bond
- L3 is selected from bond, aryl, heterocycle, heteroaryl,
- m is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10;
- R10 is selected from C1-C6alkyl, cycloalkyl, heterocycle, heteroaryl, —C1-C6alkyl-aryl, and aryl;
- each of which R10 group is optionally substituted with 1, 2, 3, or 4 substituents independently selected from R11;
- R11 is selected from hydrogen, halogen, —NR1R14, —OR11, C1-C6alkyl, C1-C6haloalkyl, —SO2NR1R14, —SO2OR14, —SONR1R14, and —S(O)OR14;
- each R12 is independently selected from hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, and C1-C6haloalkyl;
- R13 is selected from hydrogen, C1-C6alkyl, cycloalkyl, and heterocycle;
- each of which cycloalkyl and heterocycle is optionally substituted with 1, 2, 3, or 4 substituents independently selected from R11;
- and
- each instance of R14 is independently selected from hydrogen, C1-C6alkyl, C(O)alkyl, and C(O)NR1R1.
29 more elements
Dependencies are inferred from the claim text.